Acrivon Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $4.4M | 767k | 5.80 |
| 2024-03-31 | $5.3M | 744k | 7.15 |
| 2023-09-30 | $5.1M | 529k | 9.56 |
| 2023-06-30 | $6.9M | 533k | 12.96 |
| 2023-03-31 | $6.0M | 474k | 12.69 |